GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » ROE % Adjusted to Book Value

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) ROE % Adjusted to Book Value : 2.22% (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co ROE % Adjusted to Book Value?

Shenzhenlubris Pharmaceuticals Co's ROE % for the quarter that ended in Mar. 2025 was 9.09%. Shenzhenlubris Pharmaceuticals Co's PB Ratio for the quarter that ended in Mar. 2025 was 4.10. Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 was 2.22%.

Shenzhenlubris Pharmaceuticals Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co ROE % Adjusted to Book Value Chart

Shenzhenlubris Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 2.08 1.73 1.60 1.82

Shenzhenlubris Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.50 1.89 1.80 1.07 2.22

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value falls into.


;
;

Shenzhenlubris Pharmaceuticals Co ROE % Adjusted to Book Value Calculation

Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=7.19% / 3.96
=1.82%

Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.09% / 4.10
=2.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhenlubris Pharmaceuticals Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhenlubris Pharmaceuticals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
SHSE:603087 SZSE:300888 SZSE:002432 SZSE:300896 SHSE:688050 SHSE:688301 SZSE:300677 SZSE:300595 SZSE:300573 SHSE:688289 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM
Traded in Other Exchanges
N/A
Address
No. 6009 Shennan Road, 37th Floor, Main Building, Chegongmiao Lvjing Plaza, Futian District, Guangdong, Shenzhen, CHN, 518040
Website
https://www.salubris.com
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Executives
Yan Jie Directors, executives
Yang Jian Feng Secretary, Director
Zhao Song Ping Executives
Liu Jun Executives
Li Ai Zhen Supervisors
Chen Ping Executives
Ye Cheng Hai Director
Lu Feng Executives, directors
Chen Qiong Xing Supervisors
Li Ying Hui Supervisors
Pan Ling Man Independent director
Zhang Zhong Xing Executives

Shenzhenlubris Pharmaceuticals Co Headlines

No Headlines